From: The genetics and screening of familial hypercholesterolaemia
Group 1: Family History | Points |
     i. First-degree relative with premature CHDa | 1 |
     ii. First-degree relative with LDL-C > 95th percentile by age, gender for country | 1 |
     iii. First-degree relative with tendinous xanthomata and/or arcus cornealis | 2 |
     iv. Children under 18 years with LDL-C > 95th percentile by age, gender for country | 2 |
Group 2: Clinical History | Points |
     i. Premature CHD | 2 |
     ii. Premature cerebrovascular or peripheral vascular disease | 1 |
Group 3: Physical Examination Points | Â |
     i. Tendinous xanthomata | 6 |
     ii. Arcus cornealis prior to 45 years | 4 |
Group 4: LDL-C Levels | Points |
     i. LDL-C > 8.5 mmol/l (~330 mg/dl) | 8 |
     ii. LDL-C 6.5-8.4 mmol/l (~250-329 mg/dl) | 5 |
     iii. LDL-C 5.0-6.4 mmol/l (~190-249 mg/dl) | 3 |
     iv. LDL-C 4.0-4.9 mmol/l (~155-189 mg/dl) | 1 |
Group 5: DNA Analysis Points | Â |
     i. Causative mutation in the LDLR, ApoB or PCSK9 gene | 8 |
Total Score: - | |
     Definite FH > 8 points | |
     Probable FH: 6–8 points | |
     Possible FH: 3–5 points | |
     Unlikely FH: 0–2 points | |
Genetic Testing For: - | |
     i. Patients with a score > 5 points | |
     ii. Patients with an obvious diagnosis of xanthomata with high cholesterol and a CHD family history | |
Causative Mutation Found: - | |
     Genetic testing for all first degree relatives |